Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Travere Therapeutics, Inc. (RTRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/24/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/01/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 02/24/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 02/26/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 02/27/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/01/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 02/26/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/11/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/28/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 06/13/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 05/24/2012 |
10-K
| Annual Report for the period ended February 29, 2012 |
| 05/25/2011 |
10-K
| Annual Report for the period ended February 28, 2011 |
| 10/28/2010 |
10-K
| Annual Report for the period ended February 28, 2010 |
| 10/28/2010 |
10-K
| Annual Report for the period ended February 28, 2009 |
|
|